Y-Mabs Therapeutics's market cap is currently $277.69M. The company's EPS TTM is $-0.541; its P/E ratio is ―; Y-Mabs Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 84.82M	$ 65.27M	$ 34.90M	$ 20.75M	$ 0.00
Gross Profit	$ 73.40M	$ 57.70M	$ 32.38M	$ 18.55M	$ -166.00K
Operating Income	$ -25.67M	$ -94.81M	$ -115.43M	$ -119.94M	$ -83.00M
EBITDA	$ -24.94M	$ -94.73M	$ -54.49M	$ -119.54M	$ -82.84M
Net Income	$ -21.43M	$ -96.33M	$ -56.34M	$ -118.34M	$ -78.89M
Balance Sheet
Cash & Short-Term Investments	$ 78.64M	$ 105.76M	$ 181.56M	$ 114.63M	$ 207.14M
Total Assets	$ 127.87M	$ 141.46M	$ 212.78M	$ 132.05M	$ 216.37M
Total Debt	$ 1.42M	$ 1.77M	$ 3.63M	$ 3.98M	$ 2.23M
Net Debt	$ -77.22M	$ -104.00M	$ -177.93M	$ -110.66M	$ -204.91M
Total Liabilities	$ 26.88M	$ 32.23M	$ 32.68M	$ 26.21M	$ 17.46M
Stockholders' Equity	$ 100.98M	$ 109.22M	$ 180.11M	$ 105.84M	$ 198.90M
Cash Flow
Free Cash Flow	$ -27.23M	$ -75.92M	$ -103.52M	$ -91.41M	$ -75.46M
Operating Cash Flow	$ -27.23M	$ -75.92M	$ -102.56M	$ -91.23M	$ -73.50M
Investing Cash Flow	$ 0.00	$ 0.00	$ 61.04M	$ -2.79M	$ -1.97M
Financing Cash Flow	$ 100.00K	$ 84.00K	$ 108.31M	$ 2.00M	$ 134.70M

Currency in USD

Y-Mabs Therapeutics Earnings and Revenue History

Income Statement >

Y-Mabs Therapeutics Debt to Assets

Balance Sheet >

Y-Mabs Therapeutics Cash Flow

Cash Flow >

Y-Mabs Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing